 |
|
The Fate of Dacron Vascular Grafts
MICHAEL E. De BAKEY, MD;
GEORGE L. JORDAN, JR., MD;
JACK P. ABBOTT, MD;
BELA HALPERT, MD;
ROBERT M. O'NEAL, MD
AMA Arch Surg. 1964;89(5):755-782.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Truly impressive developments have taken place in recent years in the field of vascular surgery. A number of factors have been responsible for these striking advances, and among the most important has been the development of a satisfactory and effective arterial substitute. Although the use of arterial substitutes and the principles of blood vessel suture were demonstrated in experimental animals, and indeed in a few clinical cases, over a half century ago, for a number of reasons their wide clinical applicability has been a reality only a little over a decade. Indeed, the successful demonstration at that time that an arterial homograft could be used to replace a diseased arterial segment and could function effectively to provide normal arterial blood flow gave great impetus to further advancement in this field of surgery. It soon became apparent, however, that the arterial homograft was associated with a number of disadvantages, including particularly,
. . . [Full Text PDF of this Article]
Author Affiliations
HOUSTON
From the Cora and Webb Mading Department of Surgery, and the Department of Pathology, Baylor University College of Medicine, The Methodist Hospital, and the Veterans Administration Hospital.
Footnotes
Presidential Address, read before the 12th Scientific Meeting of the International Cardiovascular Society, North American Chapter, San Francisco, Calif, June 20, 1964.
Supported in part by the United States Public Health Service under grants HE-05435 and HE-03137.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
